Abstract:Developing new drugs is costly, time-consuming, and risky. Drug-target affinity (DTA), indicating the binding capability between drugs and target proteins, is a crucial indicator for drug development. Accurately predicting interaction strength between new drug-target pairs by analyzing previous experiments aids in screening potential drug molecules, repurposing them, and developing safe and effective medicines. Existing computational models for DTA prediction rely on strings or single-graph neural networks, lacking consideration of protein structure and molecular semantic information, leading to limited accuracy. Our experiments demonstrate that string-based methods may overlook protein conformations, causing a high root mean square error (RMSE) of 3.584 in affinity due to a lack of spatial context. Single graph networks also underperform on topology features, with a 6% lower confidence interval (CI) for activity classification. Absent semantic information also limits generalization across diverse compounds, resulting in 18% increment in RMSE and 5% in misclassifications within quantifications study, restricting potential drug discovery. To address these limitations, we propose G-K BertDTA , a novel framework for accurate DTA prediction incorporating protein features, molecular semantic features, and molecular structural information. In this proposed model, we represent drugs as graphs, with a GIN employed to learn the molecular topological information. For the extraction of protein structural features, we utilize a DenseNet architecture. A knowledge-based BERT semantic model is incorporated to obtain rich pre-trained semantic embeddings, thereby enhancing the feature information. We extensively evaluated our proposed approach on the publicly available benchmark datasets (i.e., KIBA and Davis), and experimental results demonstrate the promising performance of our method, which consistently outperforms previous state-of-the-art approaches. Code is available at https://github.com/AmbitYuki/G-K-BertDTA .

Hierarchical graph representation learning for the prediction of drug-target binding affinity

HiGraphDTI: Hierarchical Graph Representation Learning for Drug-Target Interaction Prediction

Drug–target affinity prediction with extended graph learning-convolutional networks

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

DeepGS: Deep Representation Learning of Graphs and Sequences for Drug-Target Binding Affinity Prediction

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug–target binding affinity prediction

GraphDTA: predicting drug-target binding affinity with graph neural networks

Hierarchical and dynamic graph attention network for drug-disease association prediction

MvGraphDTA: multi-view-based graph deep model for drug-target affinity prediction by introducing the graphs and line graphs

Drug-Target Affinity Prediction Based on Improved GraphDTA

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Prediction of Drug-Target Affinity Using Attention Neural Network

Designing an adaptive learning framework for predicting drug-target affinity using reinforcement learning and graph neural networks

HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction

G-K BertDTA: A graph representation learning and semantic embedding-based framework for drug-target affinity prediction

Predicting Drug-Target Interactions with Deep-Embedding Learning of Graphs and Sequences.

GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction

Hierarchical Multi-Relational Graph Representation Learning for Large-Scale Prediction of Drug-Drug Interactions